Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 187

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep Problems, Depression, Pain, Anxiety, and Physical Dysfunction—A Review

Open access
Mustian, Karen M, Sprod, Lisa K, Janelsins, Michelle, Peppone, Luke J, Mohile, Supriya, Assistant Professor and Director, Research Assistant Professor, Research Assistant Professor, Research Assistant Professor, Associate Professor, Physical Exercise, Activity and Kinesiology (PEAK) Laboratory, James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, New York, US · 2012 · Oncology & Hematology Review (US)

Abstract

Cancer and its treatments produce a myriad of burdensome side effects and significantly impair quality of life (QoL). Exercise reduces side effects and improves QoL for cancer patients during treatment and recovery. Exercise prior to, during, and after completion of cancer treatments provides numerous beneficial outcomes. It represents an effective therapeutic intervention for preparing patients to successfully complete treatments, for reducing acute, chronic, and late side effects, and for improving QoL during and after treatments. This overview of exercise oncology and side effect management summarizes existing evidence-based exercise guidelines for cancer patients and survivors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.17925/ohr.2012.08.2.81

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 187

Metadata

Authors
Mustian, K. M., Sprod, L. K., Janelsins, M., Peppone, L. J., Mohile, S., Director, A. P. A., Professor, R. A., Professor, R. A., Professor, R. A., & Associate Professor, P. E.
Venue
Oncology & Hematology Review (US)
Published
2012
Volume
08
Issue
02
Pages
81
ISSN
2052-3815 (ISSN-L)
OpenAlex
W166671195
Cited by
187
References
12
FWCI
2.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.